Researchers Lay Groundwork for Graphene-based Diagnostic Devices
|
By LabMedica International staff writers Posted on 18 Mar 2019 |

Image: Researchers combined graphene with nano-sized metal ribbons of gold to create an ultrasensitive biosensor that could help detect a variety of diseases in humans and animals (Photo courtesy of Oh Group, University of Minnesota).
A breakthrough in the use of graphene as a plasmon resonator for ultrasensitive infrared spectroscopy should enable development of new biosensors for detection of diseases at the molecular level.
Graphene is a form of carbon consisting of a single layer of carbon atoms arranged in a hexagonal lattice. It is a semimetal with small overlap between the valence and the conduction bands. As such, it can be considered as an indefinitely large aromatic molecule, the ultimate case of the family of flat polycyclic aromatic hydrocarbons. Graphene is the basic structural element of many other forms of carbon, such as graphite, charcoal, carbon nanotubes and fullerenes. Graphene has many uncommon properties such as being the strongest material ever tested while conducting heat and electricity efficiently and being nearly transparent.
Graphene's remarkable single atom thickness minimizes its efficiency to interact with light that is shined through it. Since light absorption and conversion to local electric fields is essential for detecting small amounts of molecules, this has prevented significant use of graphene as a basis for diagnostic devices.
Investigators at the University of Minnesota (Minneapolis/St. Paul, USA) have now combined graphene with nano-sized metal ribbons of gold. Using sticky tape and a high-tech nanofabrication technique called “template stripping,” they created an ultra-flat base layer surface for graphene that made the material suitable for use as an acoustic plasmon resonator.
Plasmon resonance is a phenomenon that occurs when light is reflected off thin metal films, which may be used to measure interaction of biomolecules on the surface. An electron charge density wave arises at the surface of the film when light is reflected at the film under specific conditions. A fraction of the light energy incident at a defined angle can interact with the delocalized electrons in the metal film (plasmon) thus reducing the reflected light intensity. The angle of incidence at which this occurs is influenced by the refractive index close to the backside of the metal film, to which target molecules are immobilized. If ligands in a mobile phase running along a flow cell bind to the surface molecules, the local refractive index changes in proportion to the mass being immobilized. This can be monitored in real time by detecting changes in the intensity of the reflected light.
The investigators reported that graphene-based acoustic plasmons allowed ultrasensitive measurements of absorption bands and surface phonon modes in ångström-thick protein and SiO2 layers, respectively. The acoustic plasmon resonator platform was scalable and could harness the ultimate level of light–matter interactions at nearly 94% efficiency for potential applications including spectroscopy, sensing, metasurfaces, and optoelectronics. When protein molecules were inserted between the graphene and metal ribbons, enough energy was harnessed to view single layers of protein molecules.
“In order to detect and treat many diseases we need to detect protein molecules at very small amounts and understand their structure,” said senior author Dr. Sang-Hyun Oh, professor of electrical and computer engineering at the University of Minnesota. “Currently, there are many technical challenges with that process. We hope that our device using graphene and a unique manufacturing process will provide the fundamental research that can help overcome those challenges. Our computer simulations showed that this novel approach would work, but we were still a little surprised when we achieved the 94% percent light absorption in real devices. Realizing an ideal from a computer simulation has so many challenges. Everything has to be so high quality and atomically flat. The fact that we could obtain such good agreement between theory and experiment was quite surprising and exciting.”
This work was detailed in the February 11, 2019, online edition of the journal Nature Nanotechnology.
Related Links:
University of Minnesota
Graphene is a form of carbon consisting of a single layer of carbon atoms arranged in a hexagonal lattice. It is a semimetal with small overlap between the valence and the conduction bands. As such, it can be considered as an indefinitely large aromatic molecule, the ultimate case of the family of flat polycyclic aromatic hydrocarbons. Graphene is the basic structural element of many other forms of carbon, such as graphite, charcoal, carbon nanotubes and fullerenes. Graphene has many uncommon properties such as being the strongest material ever tested while conducting heat and electricity efficiently and being nearly transparent.
Graphene's remarkable single atom thickness minimizes its efficiency to interact with light that is shined through it. Since light absorption and conversion to local electric fields is essential for detecting small amounts of molecules, this has prevented significant use of graphene as a basis for diagnostic devices.
Investigators at the University of Minnesota (Minneapolis/St. Paul, USA) have now combined graphene with nano-sized metal ribbons of gold. Using sticky tape and a high-tech nanofabrication technique called “template stripping,” they created an ultra-flat base layer surface for graphene that made the material suitable for use as an acoustic plasmon resonator.
Plasmon resonance is a phenomenon that occurs when light is reflected off thin metal films, which may be used to measure interaction of biomolecules on the surface. An electron charge density wave arises at the surface of the film when light is reflected at the film under specific conditions. A fraction of the light energy incident at a defined angle can interact with the delocalized electrons in the metal film (plasmon) thus reducing the reflected light intensity. The angle of incidence at which this occurs is influenced by the refractive index close to the backside of the metal film, to which target molecules are immobilized. If ligands in a mobile phase running along a flow cell bind to the surface molecules, the local refractive index changes in proportion to the mass being immobilized. This can be monitored in real time by detecting changes in the intensity of the reflected light.
The investigators reported that graphene-based acoustic plasmons allowed ultrasensitive measurements of absorption bands and surface phonon modes in ångström-thick protein and SiO2 layers, respectively. The acoustic plasmon resonator platform was scalable and could harness the ultimate level of light–matter interactions at nearly 94% efficiency for potential applications including spectroscopy, sensing, metasurfaces, and optoelectronics. When protein molecules were inserted between the graphene and metal ribbons, enough energy was harnessed to view single layers of protein molecules.
“In order to detect and treat many diseases we need to detect protein molecules at very small amounts and understand their structure,” said senior author Dr. Sang-Hyun Oh, professor of electrical and computer engineering at the University of Minnesota. “Currently, there are many technical challenges with that process. We hope that our device using graphene and a unique manufacturing process will provide the fundamental research that can help overcome those challenges. Our computer simulations showed that this novel approach would work, but we were still a little surprised when we achieved the 94% percent light absorption in real devices. Realizing an ideal from a computer simulation has so many challenges. Everything has to be so high quality and atomically flat. The fact that we could obtain such good agreement between theory and experiment was quite surprising and exciting.”
This work was detailed in the February 11, 2019, online edition of the journal Nature Nanotechnology.
Related Links:
University of Minnesota
Latest Molecular Diagnostics News
- Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
- Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
- Two-in-One DNA Analysis Improves Diagnostic Accuracy While Saving Time and Costs
- “Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
- New Tool Maps Chromosome Shifts in Cancer Cells to Predict Tumor Evolution
- Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
- Newly-Identified Parkinson’s Biomarkers to Enable Early Diagnosis Via Blood Tests
- New Blood Test Could Detect Pancreatic Cancer at More Treatable Stage
- Liquid Biopsy Could Replace Surgical Biopsy for Diagnosing Primary Central Nervous Lymphoma
- New Tool Reveals Hidden Metabolic Weakness in Blood Cancers
- World's First Blood Test Distinguishes Between Benign and Cancerous Lung Nodules
- Rapid Test Uses Mobile Phone to Identify Severe Imported Malaria Within Minutes
- Gut Microbiome Signatures Predict Long-Term Outcomes in Acute Pancreatitis
- Blood Test Promises Faster Answers for Deadly Fungal Infections
- Blood Test Could Detect Infection Exposure History
- Urine-Based MRD Test Tracks Response to Bladder Cancer Surgery
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more






 Analyzer.jpg)
